circDIDO1 suppressed the progression of GC via modulating the miR-1307-3p/SOSC2 axis.
Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis.